Information Document

Pursuant to Article 1 par. 5 point h) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, concerning the admission to trading of shares of the company “European Innovation Solutions S.A.”, with the distinctive title “E.In.S. S.A.”, formerly “Euroconsultants Development and Technology Consultants S.A.”, for the third (3rd) period of the Program, from 27.9.2025 until 26.9.2026, and in respect of rights granted to the beneficiaries by virtue of the resolution of the Board of Directors dated 9.3.2026, in implementation of the Company’s Stock Option Plan, which was established by the resolution of the Board of Directors dated 27.09.2023, pursuant to the authorisation granted by the Annual Ordinary General Meeting dated 09.06.2023, as amended and currently in force by virtue of the unanimous resolution of the 1st Repeat Ordinary General Meeting dated 24.6.2025 concerning the change of the disposal price, and duly published with the General Commercial Registry (G.E.MI.).

Thessaloniki, 5.5.2026

The société anonyme under the corporate name “European Innovation Solutions S.A.”, with the distinctive title “E.In.S. S.A.”, formerly “Euroconsultants Development and Technology Consultants S.A.”, hereinafter the “Company” or the “Issuer”, pursuant to Article 1 par. 5 point h) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, hereby informs the investing public about the approved Stock Option Plan for members of the Company’s Management and Personnel, as well as persons providing services to the Company on a regular basis, hereinafter the “Program”. The Program was established for the period from 27.9.2023 to 26.9.2026 by virtue of the resolution of the Company’s Board of Directors dated 27.09.2023, following the authorisation granted by the Ordinary General Meeting dated 09.06.2023, as amended, published and currently in force by virtue of the unanimous resolutions of the 1st Repeat Ordinary General Meeting dated 24.6.2025 concerning the change of the disposal price of the rights of the third period, as follows:

Description of the Program

On 20.6.2023, the resolution of the Annual Ordinary General Meeting of the Company’s Shareholders dated 09.06.2023 was registered with the General Commercial Registry (G.E.MI.) under Registration Code Number (K.A.K.) 3656002 by the Directorate of Companies, Listed Companies Department of the Ministry of Development and Investments. By virtue of said resolution, the Company’s Board of Directors was authorized to establish a Stock Option Plan in the form of stock options for the acquisition of newly issued shares, in accordance with Article 113 of Law 4548/2018, to be granted to members of the Company’s Management and Personnel, as well as to persons providing services to the Company on a regular basis.

The purpose of the Program is, on the one hand, to reward their active participation in achieving the Company’s strategic objectives and, on the other hand, to link their performance with the future performance of the Company and the Group in general.

For the satisfaction of the stock option rights, the Company proceeds with a share capital increase by issuing new shares, in accordance with Article 113 of Law 4548/2018 and the resolution of the Company’s Ordinary General Meeting dated 9.6.2023, which was adopted unanimously with a quorum of 72.45% on the specific item.

The total duration of the Program is three years, commencing on 27.9.2023 and ending on 26.9.2026. The above “Total Duration” of the Program is divided into three (3) separate “Annual Periods”. The “First Period” runs from 27.9.2023 to 26.9.2024. The “Second Period” runs from 27.9.2024 to 26.9.2025. The “Third Period” runs from 27.9.2025 to 26.9.2026.

The total number of rights that may be granted during the three-year duration of the Program shall not exceed rights corresponding to up to seven hundred and fifty thousand (750,000) new common registered shares of the Company, which shall be admitted to trading on the Athens Stock Exchange, currently EURONEXT ATHENS, in accordance with the applicable procedures. This number corresponds to 5.056% of the Company’s currently paid-up share capital, i.e. below the 10% limit set by Article 113 par. 2 of Law 4548/2018. The Board of Directors shall convene during each separate “Annual Period” in order to determine the beneficiaries of the stock option rights for each “Annual Period” and the number of rights allocated to each of them. The maximum number of rights that may be granted during each “Annual Period” may not exceed 250,000 rights.

In implementation of the Program, during its meeting dated 27.09.2023, the Company’s Board of Directors:

(a) approved the share disposal program in the form of stock options to members of the Company’s Management and Personnel, as well as to persons providing services to the Company on a regular basis, pursuant to the authorization granted to the Board of Directors by virtue of the resolution of the Company’s Ordinary General Meeting dated 09.06.2023;

(b) determined the stock option rights of the beneficiaries under the Program for its first year, namely for the first period from 27.9.2023 to 26.9.2024; and

(c) approved the text of the registered certificate granted for the stock option rights.

More specifically:

Description of the First Period of the Program, which has been completed and for which the relevant announcements have been made.

Following the above resolutions of the Ordinary General Meeting and the Board of Directors, the rights granted for the first period, from 27.9.2023 to 26.9.2024, vested and became exercisable in accordance with the terms of the Program as of 28.9.2023.

The exercise price of each right, which incorporates the right to acquire one new common registered share of the Company, had already been set by the resolution of the Ordinary General Meeting dated 9.6.2023 at thirty euro cents (€0.30).

Therefore, on 27.9.2023, in implementation of the above and pursuant to the authorisation granted by the General Meeting, 250,000 stock option rights were granted for the purchase of 250,000 new common registered shares. On the same day, namely 27.9.2023, ten (10) Registered Share Purchase Right Certificates were issued and delivered to the ten (10) beneficiaries of the first period of the Program.

Subsequently, on 17.10.2023, all ten (10) beneficiaries exercised all the rights granted to them without exception, namely a total of 250,000 stock option rights were exercised by written declarations for the acquisition of 250,000 common registered voting shares.

As evidenced by the Balance Certificate of OPTIMA BANK dated 20.10.2023, as well as by the bank documents delivered to the Company by the beneficiaries of the Program, during the period from 18.10.2023 to 19.10.2023, the ten (10) beneficiaries of the first annual period of the Program paid, in accordance with the terms of the Program, in cash into the special account opened by the Company for the purposes of the share capital increase under the Stock Option Plan, the total amount of seventy-five thousand euro (€75,000.00), in full payment and coverage of all 250,000 rights granted and exercised, in order for 250,000 new common registered shares to be issued. These shares, in accordance with the terms of the Program, have been admitted to trading on the Athens Stock Exchange, currently EURONEXT ATHENS, through actions taken by the Company.

The percentage represented by the exercised rights of the first period of the Program over the number of the Company’s then already listed shares amounted to 1.685% of the Company’s then existing listed shares.

The remaining rights which the Board of Directors could grant for the second period, from 27.9.2024 to 26.9.2025, amounted to 250,000 rights. These rights, as mentioned below, have already been granted and exercised and the new shares have been admitted to trading on the Athens Stock Exchange, currently EURONEXT ATHENS.

The remaining rights which the Board of Directors may grant for the third period, from 27.9.2025 to 26.9.2026, amount to 250,000 rights. These rights have also been granted and exercised, the relevant share capital increase has been completed and approved by G.E.MI., and the 250,000 new shares are in the process of being admitted to trading on the Athens Stock Exchange, currently EURONEXT ATHENS.

On 26.10.2023, the increase of the Company’s share capital by the amount of €75,000.00 through cash payment, namely the amount of €75,000.00, and the issuance of 250,000 new shares with a nominal value of €0.30 and a disposal price of €0.30 each, was registered with the General Commercial Registry (G.E.MI.) through the Directorate of Companies & G.E.MI. of the Ministry of Development and Investments, as the competent Supervisory Authority, under Registration Code Number (K.A.K.) 3833285. The certification of payment of the above share capital increase was also registered under Registration Code Number (K.A.K.) 3833373.

Following the above increase, the Company’s share capital amounted to four million five hundred twenty-five thousand forty-four euro (€4,525,044.00), fully paid up, divided into fifteen million eighty-three thousand four hundred eighty (15,083,480) common registered shares, with a nominal value of thirty euro cents (€0.30) each.

The Corporate Actions Committee of the Athens Stock Exchange, during its meeting held on 2.11.2023, approved the admission to trading of the two hundred and fifty thousand (250,000) new common registered shares. The commencement of trading of the new shares on the Athens Stock Exchange, currently EURONEXT ATHENS, was set for the second business day following the above approval of their admission, namely 6.11.2023.

Description of the Second Period of the Program, which has been completed and for which the relevant announcements have been made.

Following the above resolutions of the Ordinary General Meeting and the Board of Directors, on 24.4.2025 the Company’s Board of Directors resolved to allocate the 250,000 stock option rights of the second period, from 27.9.2024 to 26.9.2025, to nine (9) beneficiaries. These rights were granted to them on 24.4.2025 and vested in accordance with the terms of the Program as of 25.4.2025.

The exercise price of each right, which incorporates the right to acquire one new common registered share of the Company, had already been set by the resolution of the Ordinary General Meeting dated 9.6.2023 at thirty euro cents (€0.30).

Therefore, on 24.4.2025, in implementation of the above and pursuant to the authorisation granted by the General Meeting, 250,000 stock option rights were granted for the purchase of 250,000 new common registered shares. On 24.4.2025, nine (9) Registered Share Purchase Right Certificates were issued and delivered to the nine (9) beneficiaries of the second period of the Program.

Subsequently, on 12.5.2025, all nine (9) beneficiaries exercised all the rights granted to them without exception, namely a total of 250,000 stock option rights were exercised by written declarations for the acquisition of 250,000 common registered voting shares.

As evidenced by the Balance Certificate of OPTIMA BANK dated 19.5.2025, as well as by the bank documents delivered to the Company by the beneficiaries of the Program, during the period from 13.5.2025 to 16.5.2025, the nine (9) beneficiaries of the second annual period of the Program paid, in accordance with the terms of the Program, in cash into the special account opened by the Company for the purposes of the share capital increase under the Stock Option Plan, the total amount of seventy-five thousand euro (€75,000.00), in full payment and coverage of all 250,000 rights granted and exercised, in order for 250,000 new common registered shares to be issued. These shares, in accordance with the terms of the Program, have been admitted to trading on the Athens Stock Exchange, currently EURONEXT ATHENS, through actions taken by the Company.

The percentage represented by the exercised rights of the second period of the Program over the number of the Company’s then already listed shares amounted to 1.657% of the Company’s then existing listed shares.

The remaining rights which the Board of Directors may grant for the third period, from 27.9.2025 to 26.9.2026, amount to 250,000 rights. These rights have also been granted and exercised, the relevant share capital increase has been completed and approved by G.E.MI., and the 250,000 new shares are in the process of being admitted to trading on the Athens Stock Exchange, currently EURONEXT ATHENS.

On 28.05.2025, the increase of the Company’s share capital by the amount of €37,500.00 through cash payment, namely the amount of €75,000.00, and the issuance of 250,000 new shares with a nominal value of €0.15 and a disposal price of €0.30 each, was registered with the General Commercial Registry (G.E.MI.) through the Directorate of Companies & G.E.MI. of the Ministry of Development and Investments, as the competent Supervisory Authority, under Registration Code Number (K.A.K.) 3633535/28.5.2025. The certification of payment of the above share capital increase was also registered under Registration Code Number (K.A.K.) 3629794/02.06.2025. The difference between the nominal value and the disposal price, namely the amount of thirty-seven thousand five hundred euro (€37,500.00), was credited to the account “Share premium reserve”.

Following the above increase, the Company’s share capital amounted to two million three hundred thousand twenty-two euro (€2,300,022.00), fully paid up, divided into fifteen million three hundred thirty-three thousand four hundred eighty (15,333,480) common registered shares, with a nominal value of fifteen euro cents (€0.15) each.

The Athens Stock Exchange, currently EURONEXT ATHENS, on 17.6.2025 approved the admission to trading of the above 250,000 new common registered shares of the Company under the second period of the Program. From the same date, the above shares were credited to the securities accounts and investor accounts of the shareholders in the Dematerialized Securities System (D.S.S.). The commencement of trading of the new shares on the Athens Stock Exchange, currently EURONEXT ATHENS, was set for the second business day following the above approval of their admission.

Description of the Third Period of the Program, which is ongoing and in the process of completion.

Pursuant to the authorisation granted by the above General Meeting dated 9.6.2023, the Board of Directors resolved on 9.3.2026 to proceed with the allocation and disposal of all 250,000 stock option rights of the third period of the Program, from 27.9.2025 to 26.9.2026, to ten (10) beneficiaries in total, and set 9.3.2026 as the date of disposal of the rights to the beneficiaries.

The rights granted for the third period vested in accordance with the terms of the Program as of 10.3.2026.

The exercise price of each right, which incorporates the right to acquire one new common registered share of the Company, had already been set by the resolution of the Ordinary General Meeting dated 9.6.2023, as amended and currently in force by the resolutions of the 1st Repeat Ordinary General Meeting dated 24.6.2025, at ten euro cents (€0.10).

In particular, the 1st Repeat Ordinary General Meeting dated 24.6.2025 unanimously resolved, for the third remaining period of the Program, from 27.9.2025 to 26.9.2026, to amend its resolution dated 9.6.2023, as well as the relevant resolutions of the Board of Directors adopted pursuant to authorisation, by changing the disposal price of the remaining 250,000 stock option rights and setting it henceforth at the nominal value of the share applicable on the date on which the Board of Directors resolves on the allocation of the stock option rights of the third period to the beneficiaries of the Program.

The above Ordinary General Meeting also resolved that, if by the date of the Board of Directors’ resolution on the allocation of the rights of the third period the nominal value of the share has changed, the disposal price of the 250,000 remaining rights of the third period shall be automatically adjusted accordingly, so that it always corresponds to the nominal value of the share, provided of course that such rights have not already been granted to the beneficiaries.

The above resolution of the 1st Repeat Ordinary General Meeting dated 24.6.2025 was duly registered with G.E.MI. under registration number 5420970/03.07.2025 and was announced by G.E.MI. Announcement No. 3657656/03.07.2025. On the date of adoption of the above resolution, the nominal value of the share, which was subsequently reduced, was €0.15. The above amendment of the Program, namely the provision that the disposal price of the rights of the third period shall be the current nominal value of the share at the time when the Board of Directors grants the rights of the third period to the beneficiaries, was duly published with G.E.MI. by Announcement No. 3657656/03.07.2025, Registration Code Number (K.A.K.) 5420970/03.07.2025.

Subsequently, the 1st Repeat Extraordinary General Meeting dated 26.11.2025 resolved to reduce the Company’s share capital by the amount of €766,674.00 by reducing the nominal value of all 15,333,480 shares of the Company by five euro cents (€0.05) per share, namely from €0.15 to €0.10, for the purpose of returning capital in cash to the shareholders. Following the above capital reduction, the nominal value of the share was reduced from fifteen euro cents (€0.15) to ten euro cents (€0.10) per share, namely to the nominal value which the Company’s share continues to have to date. The above amendment of Article 5 of the Company’s Articles of Association, namely the capital reduction by reducing the nominal value of the share from €0.15 to €0.10, was approved by G.E.MI. by Decision No. 3877210AP/02-12-2025 (ADA: 915Φ46ΝΛΣΞ-Ν6Γ), which was registered with G.E.MI. on 02.12.2025 under registration number 5675241, as evidenced by G.E.MI. Announcement No. 3877210/02.12.2025.

Therefore, on 9.3.2026, in implementation of the above and pursuant to the authorisation granted by the General Meeting, 250,000 stock option rights were granted for the purchase of 250,000 new common registered shares. On the same day, namely 9.3.2026, ten (10) Registered Share Purchase Right Certificates were issued and delivered to the ten (10) beneficiaries of the third period of the Program.

On 10.3.2026, all ten (10) beneficiaries exercised all the rights granted to them without exception, namely a total of 250,000 stock option rights were exercised by written declarations for the acquisition of 250,000 common registered voting shares.

As evidenced by the Balance Certificate of OPTIMA BANK dated 13.3.2026, during the period from 10.3.2026 to 12.3.2026, the ten (10) beneficiaries of the third period of the Program paid, in accordance with the terms of the Program, in cash into the special account with IBAN GR61********************197 opened by the Company for the purposes of the share capital increase under the Stock Option Plan, the total amount of twenty-five thousand euro (€25,000.00), in full payment and coverage of all 250,000 rights granted and exercised, in order for 250,000 new common registered shares to be issued. These shares, in accordance with the terms of the Program, shall be admitted to trading on the Athens Stock Exchange, currently EURONEXT ATHENS, through actions taken by the Company.

On 16.3.2026, by resolution of the Board of Directors, the Company’s share capital was increased by the amount of €25,000.00, fully paid up, through cash payment in accordance with Article 113 of Law 4548/2018, and the issuance of 250,000 new common shares at a disposal price of €0.10, with a nominal value of €0.10 per share, which shall be admitted to trading on the Athens Stock Exchange, currently EURONEXT ATHENS.

On 24.3.2026, by resolution of the Board of Directors, the payment of the above share capital increase was certified.

The percentage represented by the exercised rights of the third period of the Program over the number of the Company’s already listed shares amounts to 1.630% of the Company’s currently existing listed shares.

On 02.04.2026, the increase of the Company’s share capital by the amount of €25,000.00 through cash payment and the issuance of 250,000 new shares with a nominal value of €0.10 and a disposal price of €0.10 each was registered with the General Commercial Registry (G.E.MI.) through the Directorate of Companies & G.E.MI. of the Ministry of Development and Investments, as the competent Supervisory Authority, under Protocol No. 4056168/02.04.2026.

On 02.04.2026, the certification of payment of the above share capital increase was registered with the General Commercial Registry (G.E.MI.) under Protocol No. 4056217/02.04.2026.

Following the above increase, the Company’s share capital now amounts to one million five hundred fifty-eight thousand three hundred forty-eight euro (€1,558,348.00), fully paid up, divided into fifteen million five hundred eighty-three thousand four hundred eighty (15,583,480) common registered shares, with a nominal value of ten euro cents (€0.10) each.

The total percentage represented by the rights of the third period over the number of the Company’s currently already listed shares amounts to 1.630%.

On 5.5.2026, EURONEXT ATHENS approved the admission to trading of the two hundred and fifty thousand (250,000) new common registered shares. The commencement of trading of the new shares on EURONEXT ATHENS was set for the second business day following the above approval of their admission, namely 7.5.2026.

The above 250,000 new shares were issued in the name of the Beneficiaries, namely members of the Company’s Management and Personnel, as well as persons providing services to the Company on a regular basis, who exercised the Stock Option Rights. The Company is following the procedure for the admission of the above new shares to trading on EURONEXT ATHENS, in accordance with the provisions of the EURONEXT ATHENS Rulebook and the relevant resolutions of the Board of Directors of EURONEXT ATHENS.

The new shares are expected to be admitted to trading on the second business day following the approval of their admission by EURONEXT ATHENS. These shares shall be registered in the records of EURONEXT SECURITIES ATHENS S.A., formerly the Hellenic Central Securities Depository, and in the investor accounts and securities accounts maintained by the above Beneficiaries in the Dematerialised Securities System (D.S.S.) of EURONEXT ATHENS, as provided by law.

The Company shall inform the investing public of the exact date of admission of the new shares to trading on EURONEXT ATHENS.

The persons responsible for the preparation of this Information Document and for the accuracy of its content are:

Paris Kokorotsikos, son of Stergios – Chairman and Chief Executive Officer

Efstathios Tavridis – Vice-Chairman and Chief Executive Officer

This Information Document is available to interested parties in electronic form through the Company’s website:

https://www.eins.gr/el/investors

Interested parties wishing to obtain further information may contact the Company’s Shareholders’ Service Department on business days and during business hours at +30 2310 804047, Mr. Paris Tsirchoglou.